EN 
ES 
Anna Greka, M.D., Ph.D.
Post-Doctoral Fellow
Anna Greka is an institute member of the Broad Institute of MIT and Harvard, where she directs the institute’s Kidney Disease Initiative. Greka is a physician-scientist leading the translation of scientific discoveries from the laboratory to clinical trials. She is an associate professor at Harvard Medical School (HMS); an associate physician in the Renal Division in the Department of Medicine at Brigham and Women’s Hospital (BWH); and the founding director of Kidney-NExT, a Center for Kidney Disease and Novel Experimental Therapeutics at BWH and HMS.
Boston, Massachusetts
Massachusetts General Hospital
Lay Summary of the Project:
Cells are regulated by signals that direct the movement of substances into and out of the cells through pores or channels. Channels in the podocytes interact, and a mutation in a gene of one ion channel (TRPC6) is linked to podocyte injury and may play a role in FSGS. Dr. Greka is studying the mechanisms that control channels to help identify a possible cause of FSGS. Findings may help identify targets for the development of drug therapies.
